Carboxymethyl high amylose starch (CM-HAS) as excipient for Escherichia coli oral formulations

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 60, Issue 1, 2005, Pages 53-60

  Calinescu, Carmen ^a   Mulhbacher, Jérôme ^a   Nadeau, Éric ^b   Fairbrother, John Morris ^b   Mateescu, Mircea Alexandru ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Carboxymethyl high amylose starch; Drug delivery; Escherichia coli; Gastric resistance; Intestinal matrix dissolution; Oral administration; Probiotics; Vaccin

Indexed keywords

CARBOXYMETHYL HIGH AMYLOSE STARCH; CHLOROACETIC ACID; EXCIPIENT; HYLON VII; POLYMER; STARCH; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; BACTERIAL SURVIVAL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HYDROLYSIS; DRUG SOLUBILITY; ESCHERICHIA COLI; FREEZE DRYING; FREEZING; INTESTINE; ORAL DRUG ADMINISTRATION; POWDER; STOMACH PH; STOMACH PROTECTION; SUBSTITUTION REACTION; SURVIVAL RATE; SYNTHESIS; TABLET COMPRESSION; WETTABILITY;

EID: 17444364094     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2004.12.006     Document Type: Article

References (25)

1. J.H. Eldridge, R.M. Gilley, J.K. Staas, Z. Moldoveanu, J.A. Meulbroek, and T.R. Tice Biodegradable microspheres: vaccine delivery system for oral immunization Curr. Top. Microbiol. Immunol. 146 1989 59 66
2. R.K. Gupta, A.C. Chang, and G.R. Siber Biodegradable polymer microspheres as vaccine adjuvants and delivery systems Dev. Biol. Stand. 92 1998 63 78
3. G. Mutwiri, T. Bowersock, A. Kidane, M. Sanchez, V. Gerdts, L.A. Babiuk, and P. Griebel Induction of mucosal immune responses following enteric immunization with antigen delivered in alginate microspheres Vet. Immunol. Immunopathol. 87 2002 269 276
4. B. Rihova Immunomodulating activities of soluble synthetic polymer-bound drugs Adv. Drug Deliv. Rev. 54 2002 653 674
5. R. Edelman, R.G. Russell, G. Losonsky, B.D. Tall, C.O. Tacket, M.M. Levine, and D.H. Lewis Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide) Vaccine 11 1993 155 158
6. H. Roper Applications of starch and its derivatives Carbohydr. Eur. 15 1996 14 21
7. Y. Dumoulin, S. Alex, P. Szabo, L. Cartilier, and M.A. Mateescu Cross-linked amylose as matrix for drug controlled release.X-ray and FT-IR structural analysis Carbohydr. Polym. 37 1998 361 370
8. P. Ispas-Szabo, F. Ravenelle, I. Hassan, M. Preda, and M.A. Mateescu Structure-properties relationship in cross-linked high-amylose stach for use in controlled drug release Carbohydr. Res. 323 2000 163 175
9. H.D. Schell, M. Serban, M.A. Mateescu, and T. Bentia Acid and basic amylose ionic exchangers Rev. Roumaine Chim. 23 1978 1143 1147
10. J. Mulhbacher, P. Ispas-Szabo, V. Lenaerts, and M.A. Mateescu Cross-linked high amylose starch derivatives as matrices for controlled release of high drug loadings J. Control. Rel. 76 2001 51 58
11. J. Kost, and S. Shefer Chemically-modified polysaccharides for enzymatically-controlled oral drug delivery Biomaterials 11 1990 695 698
12. H.U. Bertchinger, and J.M. Fairbrother Escherichia coli infections B.E. Straw S. D'Allaire W.L. Mengeling D.J. Taylor Diseases of swine Eighth ed. 1999 Iowa State University Press 431 468
13. G.W. Jones, and J.M. Rutter Role of the K88 antigen in the pathogenesis of neonatal diarrhea caused by Escherichia coli in piglets Infect. Immun. 6 1972 918 927
14. H.U. Bertschinger, M. Bachmann, C. Mettler, A. Pospischil, E.M. Schraner, and M. Stamm Adhesive fimbriae produced in vivo by Escherichia coli O139:K12(B):H1 associated with enterotoxaemia in pigs Vet. Microbiol. 25 1990 267 281
15. J.M. Rutter, and G.W. Jones Protection against enteric disease caused by Escherichia coli - a model for vaccination with a virulence determinant? Nature 242 1973 531 532
16. A.T. Bianchi, J.W. Scholten, A.M. Van Zijderveld, F.G. Van Zijderveld, and B.A. Bokhout Parenteral vaccination of mice and piglets with F4+ Escherichia coli suppresses the enteric anti-F4 response upon oral infection Vaccine 14 1996 199 206
17. W. Van den Broeck, E. Cox, and B.M. Goddeeris Induction of immune responses in pigs following oral administration of purified F4 fimbriae Vaccine 17 1999 2020 2029
18. US Pharmacopeia National Formulary USP XXVII, NF XXII, United States Pharmacopeial Convention Inc., Rockville, MD, 2003.
19. G. Noelting, and P. Bernfeld Diastatic enzymes, III. β-amylase. Determination of activity and control of absence of α-amylase Helv. Chim. Acta 31 1948 286 290
20. K. Kachrimanis, and S. Malamataris 'Apparent' Young's elastic modulus and radial recovery for some tableted pharmaceutical excipients Eur. J. Pharm. Sciences 21 2004 197 207
21. J. Mulhbacher, K. McGeeney, P. Ispas-Szabo, V. Lenaerts, and M.A. Mateescu Modified high amylose starch for immobilization of uricase for therapeutic application Biotechnol. Appl. Biochem. 36 2002 163 170
22. J.L. Bundy, and C. Fenselau Lectin and carbohydrate affinity capture surfaces for mass spectrometric analysis of microorganisms Anal. Chem. 73 2001 751 757
23. I.M. Helander, E.L. Nurmiaho-Lassila, R. Ahvenainen, J. Rhoades, and S. Roller Chitosan disrupts the barrier properties of the outer membrane of Gram-negative bacteria Int. J. Food Microbiol. 71 2001 235 244
24. Y. Dumoulin, L.H. Cartilier, and M.A. Mateescu Cross-linked amylose tablets containing α-amylase: an enzymatically-controlled drug release system J. Control. Rel. 60 1999 161 167
25. C. Chebli, and L. Cartilier Effect of some physical parameters on the sustained drug-release properties of substituted amylose matrices Int. J. Pharm. 193 2000 167 173